Nanoligent: designing
Designing precision medicines


Nanoligent is a spin-off of the Universitat Autónoma de Barcelona (UAB) and Hospital Sant Pau and it is based in the research park of the UAB.

The company was stablished on March 2017 by professors Dr. A. Villaverde and Dra. E. Vázquez from the Nanobiotecnology Group of the UAB, professor Dr. M. Mangués from the Research Institut of Hospital de Sant Pau, and entrepreneur Dr. M. Rodríguez.

We cooperate with the following top world-class research centers:

 


 

  • Nanobiotechnology group at the Institute of Biotecnology and Biomedicine, Universitat Autonoma de Barcelona.

  • Departament of Genetics and Microbiology of the Universitat Autonoma de Barcelona.

 

  • Oncogenesis and Antitumorals Drugs Group of Institut d'Investigacions Biomèdiques Sant Pau (IIB-Sant Pau) from Hospital de la Santa Creu i Sant Pau of Barcelona.

  • CIBER (Network biomedical research center) of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) Bellaterra